Any hypertrophic cardiomyopathy in which the cause of the disease is a mutation in the MYH7 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning hypertrophic cardiomyopathy 1
Updated Feb 4, 2026
A recent study highlights PRKAG2 cardiac syndrome as a rare condition that can mimic hypertrophic cardiomyopathy in adolescents. This discovery emphasizes the need for accurate diagnosis in patients presenting with unexplained cardiac hypertrophy and conduction system disease.